| Quyen Trinh, DO | |
|
21770 Kingsland Blvd, Katy, TX 77450-2513 | |
| (281) 646-0740 | |
| (281) 646-0743 |
| Full Name | Quyen Trinh |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 28 Years |
| Location | 21770 Kingsland Blvd, Katy, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033205224 | NPI | - | NPPES |
| 130856101 | Medicaid | TX | |
| 140922901 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | L1224 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hermann Katy Hospital | Katy, TX | Hospital |
| Houston Methodist West Hospital | Houston, TX | Hospital |
| Entity Name | Kelsey-seybold Medical Group, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013915255 PECOS PAC ID: 9739093527 Enrollment ID: O20031117000204 |
News Archive
Cancer-control researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and the University of Kentucky aim to increase colorectal cancer screening and follow-up care among underserved individuals in Appalachia through a multi-institutional $5.7 million grant from the National Cancer Institute.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today reported its financial results for the second quarter ended June 30, 2010.
The biggest killer of women over the age of 50 is heart disease. By age 65 women have the same heart attack or stroke risk as men and a greater risk of dying from either. To help better predict heart attack risk in these women, Atherotech Diagnostics Lab has developed a new and better way to test for heart disease risk. The new test will soon be available exclusively through Atherotech Diagnostics Lab.
American pharmaceutical manufacturer Alpharma Inc. has agreed to pay $42.5 million to resolve False Claims Act allegations in connection with the marketing of the morphine-based drug, Kadian, the Justice Department announced today. The settlement resolves allegations that, between January 1, 2000 and December 29, 2008, Alpharma paid health care providers to induce them to promote or prescribe Kadian, and made misrepresentations about the safety and efficacy of the drug, which is used to treat chronic moderate to severe pain.
› Verified 8 days ago
| Entity Name | Trang Thuy Trinh Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053592949 PECOS PAC ID: 0345303095 Enrollment ID: O20190919000286 |
News Archive
Cancer-control researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and the University of Kentucky aim to increase colorectal cancer screening and follow-up care among underserved individuals in Appalachia through a multi-institutional $5.7 million grant from the National Cancer Institute.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today reported its financial results for the second quarter ended June 30, 2010.
The biggest killer of women over the age of 50 is heart disease. By age 65 women have the same heart attack or stroke risk as men and a greater risk of dying from either. To help better predict heart attack risk in these women, Atherotech Diagnostics Lab has developed a new and better way to test for heart disease risk. The new test will soon be available exclusively through Atherotech Diagnostics Lab.
American pharmaceutical manufacturer Alpharma Inc. has agreed to pay $42.5 million to resolve False Claims Act allegations in connection with the marketing of the morphine-based drug, Kadian, the Justice Department announced today. The settlement resolves allegations that, between January 1, 2000 and December 29, 2008, Alpharma paid health care providers to induce them to promote or prescribe Kadian, and made misrepresentations about the safety and efficacy of the drug, which is used to treat chronic moderate to severe pain.
› Verified 8 days ago
| Entity Name | Striker Infusion Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104454354 PECOS PAC ID: 5193148328 Enrollment ID: O20200707002264 |
News Archive
Cancer-control researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and the University of Kentucky aim to increase colorectal cancer screening and follow-up care among underserved individuals in Appalachia through a multi-institutional $5.7 million grant from the National Cancer Institute.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today reported its financial results for the second quarter ended June 30, 2010.
The biggest killer of women over the age of 50 is heart disease. By age 65 women have the same heart attack or stroke risk as men and a greater risk of dying from either. To help better predict heart attack risk in these women, Atherotech Diagnostics Lab has developed a new and better way to test for heart disease risk. The new test will soon be available exclusively through Atherotech Diagnostics Lab.
American pharmaceutical manufacturer Alpharma Inc. has agreed to pay $42.5 million to resolve False Claims Act allegations in connection with the marketing of the morphine-based drug, Kadian, the Justice Department announced today. The settlement resolves allegations that, between January 1, 2000 and December 29, 2008, Alpharma paid health care providers to induce them to promote or prescribe Kadian, and made misrepresentations about the safety and efficacy of the drug, which is used to treat chronic moderate to severe pain.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Quyen Trinh, DO 21770 Kingsland Blvd, Katy, TX 77450-2513 Ph: (281) 646-0740 | Quyen Trinh, DO 21770 Kingsland Blvd, Katy, TX 77450-2513 Ph: (281) 646-0740 |
News Archive
Cancer-control researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and the University of Kentucky aim to increase colorectal cancer screening and follow-up care among underserved individuals in Appalachia through a multi-institutional $5.7 million grant from the National Cancer Institute.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today reported its financial results for the second quarter ended June 30, 2010.
The biggest killer of women over the age of 50 is heart disease. By age 65 women have the same heart attack or stroke risk as men and a greater risk of dying from either. To help better predict heart attack risk in these women, Atherotech Diagnostics Lab has developed a new and better way to test for heart disease risk. The new test will soon be available exclusively through Atherotech Diagnostics Lab.
American pharmaceutical manufacturer Alpharma Inc. has agreed to pay $42.5 million to resolve False Claims Act allegations in connection with the marketing of the morphine-based drug, Kadian, the Justice Department announced today. The settlement resolves allegations that, between January 1, 2000 and December 29, 2008, Alpharma paid health care providers to induce them to promote or prescribe Kadian, and made misrepresentations about the safety and efficacy of the drug, which is used to treat chronic moderate to severe pain.
› Verified 8 days ago
Dr. Shamim Ali, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 707 S Fry Rd, Suite 360, Katy, TX 77450 Phone: 281-599-9979 Fax: 281-599-3540 | |
Severino Pimentel, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 21304 Provincial Blvd, Katy, TX 77450 Phone: 281-206-8280 Fax: 281-206-8285 | |
Dr. Molly Magdalene Nakyonyi-ntwatwa, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2510 W Grand Pkwy N, Katy, TX 77449 Phone: 713-442-4222 | |
Behrooz Saffari, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 23923 Cinco Ranch Blvd, Katy, TX 77494 Phone: 713-486-5300 | |
Eric Samuel Colletti, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 21700 Kingsland Blvd Ste 201, Katy, TX 77450 Phone: 281-398-7954 Fax: 281-578-4912 | |
Yanielka Cordova Garcia, APRN Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 22611 Cremona Village Trl, Katy, TX 77449 Phone: 346-970-9490 |